Tracking estimates for *Clayface* cluster in the mid-to-high $20 million range domestically, reflecting limited awareness and presales that initially trailed comparable horror titles, even as the $30–40 million budget positions the film for profitability at those levels. Positive early critic reactions to its R-rated body horror approach and strong intent among the aware audience have supported momentum toward the upper end of forecasts, with light competition from *Wildwood* and others aiding the Halloween-timed release. Traders appear to weigh the risk of subdued crossover appeal for the B-list Batman villain against potential word-of-mouth upside ahead of the October 23 debut.